Alterations in cortisol and interleukin-6 secretion in patients with COVID-19 suggestive of neuroendocrine-immune adaptations

PURPOSE: The beneficial effect of glucocorticoids in coronavirus disease (COVID-19) is established, but whether adrenal cortisol secretion is impaired in COVID-19 is not fully elucidated. In this case-control study, we investigated the diurnal free bioavailable salivary cortisol secretion in COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Yavropoulou, Maria P., Filippa, Maria G., Mantzou, Aimilia, Ntziora, Fotinie, Mylona, Maria, Tektonidou, Maria G., Vlachogiannis, Nikolaos I., Paraskevis, Dimitrios, Kaltsas, Gregory A., Chrousos, George P., Sfikakis, Petros P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765492/
https://www.ncbi.nlm.nih.gov/pubmed/35043384
http://dx.doi.org/10.1007/s12020-021-02968-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765492/
https://www.ncbi.nlm.nih.gov/pubmed/35043384
http://dx.doi.org/10.1007/s12020-021-02968-8

Ejemplares similares